Full enrollment in ongoing global, pivotal Phase 3 clinical trial in chronic neutropeniaon track for mid-2025 Right-sizing commercial efforts to optimize XOLREMDI promotion and support U.S. WHIM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback